| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |